Streetbeat News

Analyst Ratings

ARCH

In the last quarter, Arch Resources (NYSE:ARCH) received 4 bullish analyst ratings. The company has an average 12-month price target of $190.0, a decrease of 3.06% from the previous average price target of $196.00.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

RCUS

Arcus Biosciences (NYSE:RCUS) has received mostly bullish ratings from analysts in the last quarter, with 5 bullish, 4 somewhat bullish, and 1 indifferent rating. The average 12-month price target for the stock, according to 10 analysts, is $46.5, with a high of $70.00 and a low of $23.00. This average price target has increased by 36.76% over the past month.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

WING

Truist Securities analyst Jake Bartlett has reiterated a 'Hold' rating on Wingstop (NASDAQ:WING) and maintained a price target of $191.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:59 pm

IQV

Truist Securities analyst Jailendra Singh has reiterated a 'Buy' rating on IQVIA Holdings (IQV) and maintained a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:57 pm

HASI

Morgan Stanley has maintained an Equal-Weight rating on Hannon Armstrong Sustainable Infrastructure (HASI) but lowered its price target from $26 to $23. This has led to a decrease in HASI's share price.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:55 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) shares are trading lower, with the stock down more than 12% over the last month. Barclays and Susquehanna analysts have maintained their ratings but lowered the price targets for ENPH. The stock has seen heavy trading volume and has attracted the attention of retail investors and short-sellers. ENPH shares are currently down 3.7% at $112.52.

Portfolio Pulse from Erica Kollmann

October 03, 2023 | 3:55 pm

NEP

NextEra Energy Partners' shares are trading lower after Morgan Stanley maintained an Equal-Weight rating on the stock but lowered its price target from $65 to $31.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:53 pm

ANEB

Benchmark analyst Robert Wasserman has reiterated a Speculative Buy on Anebulo Pharmaceuticals (NASDAQ:ANEB) and maintained an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:52 pm

SYM

Goldman Sachs has maintained a Neutral rating for Symbotic but lowered its price target from $41 to $36. This has led to a decrease in Symbotic's share price.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:50 pm

SPR

Benchmark analyst Josh Sullivan has reiterated a 'Buy' rating on Spirit AeroSystems Hldgs (NYSE:SPR) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 3:49 pm